Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
about
Actions of two main metabolites of propiverine (M-1 and M-2) on voltage-dependent L-type Ca2+ currents and Ca2+ transients in murine urinary bladder myocytes.Age-dependent contribution of Rho kinase in carbachol-induced contraction of human detrusor smooth muscle in vitroEfficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study.The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum.Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder.Influence of a fat-rich meal on bioavailability of extended-release and immediate-release propiverine.Efficacy and Safety of Propiverine and Solifenacin for the Treatment of Female Patients with Overactive Bladder: A Crossover Study.Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms.
P2860
Q30483622-69C3E5A9-C0FF-4C14-96EB-312DED682E91Q33823666-610A05F9-B0B7-4687-A6F8-A5DA022A3129Q34709479-B6AD074E-EA32-4894-90F0-2D1311C0E716Q34709612-8E1AE670-835B-43EB-A826-F87CF20E3C81Q38071594-52008B31-709D-4534-B94B-2CC7F47FE932Q38336214-E6A7024D-F37E-4292-9A69-32EEB1135388Q45389301-C87EB6DA-75D5-4C77-B9BD-2B165AF1806DQ50907877-A66AFE9F-CB12-4849-9865-1D19172EFFCAQ51373576-46A80114-7ECC-43CF-90B3-A22BF1A90A74Q51484228-95B0B048-8599-4521-B312-4883D82C2C04Q54543594-957EA903-96A5-4D44-AEE0-644DB34CED7E
P2860
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@ast
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@en
type
label
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@ast
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@en
prefLabel
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@ast
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@en
P2093
P2860
P356
P1476
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction
@en
P2093
Christian Schoeberl
Juliane Hecht
Manfred Braeter
Manfred P Wirth
Melinda Wuest
Oliver W Hakenberg
Torsten Christ
Ursula Ravens
P2860
P304
P356
10.1038/SJ.BJP.0706244
P407
P577
2005-07-01T00:00:00Z